𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nonpalpable prostate cancer detected in the prostate-specific antigen era

✍ Scribed by H. Ballentine Carter

Publisher
Springer-Verlag
Year
1997
Tongue
English
Weight
134 KB
Volume
15
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prostate-specific antigen in screening o
Prostate-specific antigen in screening of prostate cancer
✍ Dr. T. Ming Chu πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 467 KB πŸ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

An algorithm for prostate cancer detecti
An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density
✍ M. C. Benson; D. J. McMahon; W. H. Cooner; C. A. Olsson πŸ“‚ Article πŸ“… 1993 πŸ› Springer-Verlag 🌐 English βš– 818 KB

Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CAP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequen

Uptake of prostate-specific antigen test
Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden
✍ HΓ₯kan Jonsson; Benny HolmstrΓΆm; Stephen W. Duffy; PΓ€r Stattin πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 792 KB

## Abstract The aim of our study was to estimate uptake of prostate‐specific antigen (PSA) testing in an entire country, including time trends and geographical differences. Data from the Swedish Cancer Register on prostate cancer incidence between 1980 and 2007 and published data from the Gothenbur